{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:41:29Z","timestamp":1792611689456,"version":"4.5.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>The US Food and Drug Administration approved the first over-the-counter (OTC) oral contraceptive pill (OCP) in 2023, potentially expanding access to contraception. Understanding whether OTC availability reaches individuals with systemic barriers to care is essential to assessing its public health impact.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate whether the newly available OTC progestin-only OCP is reaching individuals not previously using contraception or who rely on less-effective methods.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cross-sectional study used baseline data from a national, prospective US cohort. Participants were individuals aged 15 to 45 years obtaining OCPs at pharmacies or online between April 2024 and February 2025. Participants were eligible if they obtained an OCP (prescription or OTC) for contraceptive use and were at risk of pregnancy.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Obtaining an OTC progestin-only OCP vs a prescription OCP.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>Primary outcomes were (1) initiation of contraception among individuals previously not using any modern method and (2) transition from a less-effective method (eg, condoms or emergency contraception) to OCP use. Multivariable logistic regression models with robust SEs were used to determine adjusted absolute estimated probabilities and percentage point differences in outcomes.<\/jats:p><\/jats:sec>Results<\/jats:title>The sample included 986 individuals, predominantly single (692 participants [70.2%]), and the largest proportion was aged 20 to 24 years (338 participants [34.3%]). OTC OCP users accounted for 320 (32.5%) of the participants. Individuals using the OTC option were more likely to be uninsured (101 participants [31.6%] vs 23 participants [3.5%]) and to reside in rural areas (46 participants [14.4%] vs 56 participants [8.4%]) compared with prescription users. Groups did not differ in fertility preferences. OTC use of contraception was associated with a 31.8 percentage point increase (95% CI, 24.1-39.5 percentage points) in moving from nonuse of contraception to the OTC pill, when compared with prescription OCP users. Similarly, OTC access was associated with a 41.0 percentage point increase (95% CI, 33.8-48.1 percentage points) in transitioning from use of a less-effective method of contraception to the OTC pill.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this cross-sectional study of US individuals obtaining oral contraception, the OCP was accessed OTC by many who previously used no method or less-effective contraception. These findings suggest that OTC access may improve equitable access to contraception.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.27438","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T15:31:19Z","timestamp":1755531079000},"page":"e2527438","source":"Crossref","is-referenced-by-count":13,"title":["Over-the-Counter Oral Contraceptive Use and Initiation of Contraception"],"prefix":"10.1001","volume":"8","author":[{"given":"Maria I.","family":"Rodriguez","sequence":"first","affiliation":[{"name":"Center for Reproductive Health Equity, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Burns","sequence":"additional","affiliation":[{"name":"Center for Reproductive Health Equity, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reed","family":"Sheridan","sequence":"additional","affiliation":[{"name":"Center for Reproductive Health Equity, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison B.","family":"Edelman","sequence":"additional","affiliation":[{"name":"Center for Reproductive Health Equity, Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,8,18]]},"reference":[{"issue":"4","key":"zoi250775r1","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/AOG.0000000000003474","article-title":"Over-the-counter access to hormonal contraception: ACOG Committee Opinion Summary, number 788.","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"5","key":"zoi250775r2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jama.2023.10825","article-title":"Over-the-counter oral contraception as an opportunity to reduce contraceptive access inequity.","volume":"330","author":"Brandi","year":"2023","journal-title":"JAMA"},{"issue":"195","key":"zoi250775r4","first-page":"1","article-title":"Contraceptive methods women have ever used: United States, 2015\u20132019.","author":"Daniels","year":"2023","journal-title":"Natl Health Stat Report"},{"issue":"1","key":"zoi250775r5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.contraception.2012.11.021","article-title":"Prescription requirements and over-the-counter access to oral contraceptives: a global review.","volume":"88","author":"Grindlay","year":"2013","journal-title":"Contraception"},{"issue":"3","key":"zoi250775r6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/AOG.0b013e31820b0244","article-title":"Contraindications to combined oral contraceptives among over-the-counter compared with prescription users.","volume":"117","author":"Grossman","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"4","key":"zoi250775r9","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"zoi250775r12","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1377\/hlthaff.2022.00992","article-title":"Geographic variation in effective contraceptive use among Medicaid recipients in 2018.","volume":"42","author":"Rodriguez","year":"2023","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"zoi250775r13","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ajog.2009.08.022","article-title":"Disparities in family planning.","volume":"202","author":"Dehlendorf","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"2 Pt 1","key":"zoi250775r14","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1097\/01.AOG.0000443278.06393.d6","article-title":"ACOG Committee Opinion No. 586: Health disparities in rural women.","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"2","key":"zoi250775r15","doi-asserted-by":"publisher","DOI":"10.1093\/haschl\/qxae016","article-title":"Has the fall of Roe changed contraceptive access and use? new research from four US states offers critical insights.","volume":"2","author":"Kavanaugh","year":"2024","journal-title":"Health Aff Sch"},{"issue":"15","key":"zoi250775r16","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1001\/jama.2024.28527","article-title":"US abortion bans and fertility.","volume":"333","author":"Bell","year":"2025","journal-title":"JAMA"},{"issue":"5","key":"zoi250775r17","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/AOG.0000000000005144","article-title":"State variation in severe maternal morbidity among individuals with Medicaid insurance.","volume":"141","author":"Admon","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"1","key":"zoi250775r18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.21106\/ijma.444","article-title":"Trends and social inequalities in maternal mortality in the United States, 1969\u20132018.","volume":"10","author":"Singh","year":"2021","journal-title":"Int J MCH AIDS"},{"issue":"4","key":"zoi250775r19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.whi.2023.04.007","article-title":"Abortion bans will exacerbate already severe racial inequities in maternal mortality.","volume":"33","author":"Treder","year":"2023","journal-title":"Womens Health Issues"},{"issue":"5","key":"zoi250775r20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.contraception.2019.07.139","article-title":"Predicted changes in abortion access and incidence in a post-Roe world.","volume":"100","author":"Myers","year":"2019","journal-title":"Contraception"},{"issue":"2","key":"zoi250775r21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1363\/psrh.12224","article-title":"Characteristics of abortion patients in protected and restricted states accessing clinic-based care 12?months prior to the elimination of the federal constitutional right to abortion in the United States.","volume":"55","author":"Jones","year":"2023","journal-title":"Perspect Sex Reprod Health"},{"issue":"6","key":"zoi250775r22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1089\/jwh.2020.8606","article-title":"Severe maternal morbidity, race, and rurality: trends using the National Inpatient Sample, 2012\u20132017.","volume":"30","author":"Luke","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"key":"zoi250775r23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.annepidem.2019.02.007","article-title":"Racial and ethnic disparities in severe maternal morbidity prevalence and trends.","volume":"33","author":"Leonard","year":"2019","journal-title":"Ann Epidemiol"},{"issue":"3","key":"zoi250775r24","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/bmjsrh-2020-200778","article-title":"Over-the-counter oral contraceptive use among women in Mexico: results from a national survey.","volume":"47","author":"Grindlay","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"issue":"6","key":"zoi250775r26","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/jama.2024.11715","article-title":"Changes in emergency contraceptive fills after Massachusetts\u2019 statewide standing order.","volume":"332","author":"Qato","year":"2024","journal-title":"JAMA"},{"issue":"4","key":"zoi250775r27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.6044","article-title":"Contraception usage and workforce trends through 2022.","volume":"7","author":"Strasser","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi250775r28","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1001\/jamainternmed.2024.8149","article-title":"Post-Dobbs decision changes in obstetrics and gynecology clinical workforce in states with abortion restrictions.","volume":"185","author":"Zhu","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"2","key":"zoi250775r33","doi-asserted-by":"publisher","first-page":"115.e1","DOI":"10.1016\/j.ajog.2010.04.017","article-title":"The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception.","volume":"203","author":"Secura","year":"2010","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"zoi250775r34","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.contraception.2006.07.006","article-title":"Birth control within reach: a national survey on women\u2019s attitudes toward and interest in pharmacy access to hormonal contraception.","volume":"74","author":"Landau","year":"2006","journal-title":"Contraception"},{"key":"zoi250775r3","unstructured":"Daniels? K, Abma? JC. Current contraceptive status among women aged 15-49: United States, 2015-2017. NCHS Data Brief No. 327. National Center for Health Statistics. December 2018. Accessed February 3, 2024. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db327.htm"},{"key":"zoi250775r7","unstructured":"US Food and Drug Administration. FDA approves first nonprescription daily oral contraceptive. July 13, 2023. Accessed April 10, 2025. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-nonprescription-daily-oral-contraceptive"},{"key":"zoi250775r8","unstructured":"Guttmacher Institute. Challenges to the Title X program. February 2025. Accessed April 10, 2025. https:\/\/www.guttmacher.org\/fact-sheet\/challenges-title-x-program"},{"key":"zoi250775r10","unstructured":"University of Washington Rural Health Research Center. Rural-Urban Commuting Area codes (RUCAs). 2005 Accessed April 10, 2025. https:\/\/depts.washington.edu\/uwruca\/ruca-uses.php"},{"key":"zoi250775r11","unstructured":"US Census Bureau. Geographic levels. Accessed April 10, 2025. https:\/\/www.census.gov\/programs-surveys\/economic-census\/guidance-geographies\/levels.html"},{"key":"zoi250775r25","unstructured":"Coalition to Expand Contraceptive Access. Developing a post-Roe contraceptive access strategy: findings report. 2024. Accessed April 10, 2025. https:\/\/www.contraceptionaccess.org\/post-roe-strategy"},{"key":"zoi250775r29","unstructured":"Dawson? R. Trump administration\u2019s domestic gag rule has slashed the Title X network\u2019s capacity by half. February 2020. Accessed February 5, 2025. https:\/\/www.guttmacher.org\/article\/2020\/02\/trump-administrations-domestic-gag-rule-has-slashed-title-x-networks-capacity-half"},{"key":"zoi250775r30","unstructured":"Piecora? C, Yim? YM. Insurance coverage for OTC contraception. December 14, 2023. Accessed April 10, 2025. https:\/\/healthlaw.org\/insurance-coverage-for-otc-contraception\/"},{"key":"zoi250775r31","unstructured":"Long? M, Sobel? L, Salganicoff? A. Insurance coverage of OTC oral contraceptives: lessons from the field. Kaiser Family Foundation. September 14, 2023. Accessed April 10, 2025. https:\/\/www.kff.org\/womens-health-policy\/report\/insurance-coverage-of-otc-oral-contraceptives-lessons-from-the-field\/"},{"key":"zoi250775r32","unstructured":"Opill. Daily oral contraceptive pill. 2025. Accessed April 10, 2025. https:\/\/opill.com\/products\/opill"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2837663\/rodriguez_2025_oi_250775_1754671700.70688.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T15:31:20Z","timestamp":1755531080000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2837663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,18]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.27438","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,18]]}}}